ALERT: This system is being upgraded on Tuesday December 12. It will not be available
for use for several hours that day while the upgrade is in progress. Deposits to DukeSpace
will be disabled on Monday December 11, so no new items are to be added to the repository
while the upgrade is in progress. Everything should be back to normal by the end of
day, December 12.
Randomized trial comparing mindfulness training for smokers to a matched control.
Abstract
Smoking continues to take an enormous toll on society, and although most smokers would
like to quit, most are unsuccessful using existing therapies. These findings call
on researchers to develop and test therapies that provide higher rates of long-term
smoking abstinence. We report results of a randomized controlled trial comparing a
novel smoking cessation treatment using mindfulness training to a matched control
based on the American Lung Association's Freedom From Smoking program. Data were collected
on 175 low socioeconomic status smokers in 2011-2012 in a medium sized midwestern
city. A significant difference was not found in the primary outcome; intent-to-treat
biochemically confirmed 6-month smoking abstinence rates were mindfulness=25.0%, control=17.9%
(p=0.35). Differences favoring the mindfulness condition were found on measures of
urges and changes in mindfulness, perceived stress, and experiential avoidance. While
no significant differences were found in quit rates, the mindfulness intervention
resulted in positive outcomes.
Type
Journal articleSubject
Freedom from smokingMeditation
Mindfulness
Smoking
Tobacco
Adult
Cognitive Therapy
Female
Humans
Male
Meditation
Middle Aged
Mindfulness
Nicotine
Nicotinic Agonists
Patient Compliance
Smoking Cessation
Tobacco Use Disorder
Treatment Outcome
Permalink
https://hdl.handle.net/10161/11686Published Version (Please cite this version)
10.1016/j.jsat.2014.04.005Publication Info
Davis, James M; Manley, Alison R; Goldberg, Simon B; Smith, Stevens S; & Jorenby,
Douglas E (2014). Randomized trial comparing mindfulness training for smokers to a matched control.
J Subst Abuse Treat, 47(3). pp. 213-221. 10.1016/j.jsat.2014.04.005. Retrieved from https://hdl.handle.net/10161/11686.This is constructed from limited available data and may be imprecise. To cite this
article, please review & use the official citation provided by the journal.
Collections
More Info
Show full item recordScholars@Duke
James Davis
Associate Professor of Medicine
Dr. James Davis is a practicing physician of Internal Medicine, and serves as the
Medical Director for Duke Center for Smoking Cessation, Director of the Duke Smoking
Cessation Program and Co-Director of the Duke-UNC Tobacco Treatment Specialist Credentialing
Program. His research focuses on development of new pharmaceutical treatments for
smoking cessation. He is principal investigator on several trials including a study
on “adaptive” smoking cessation and several trials

Articles written by Duke faculty are made available through the campus open access policy. For more information see: Duke Open Access Policy
Rights for Collection: Scholarly Articles
Works are deposited here by their authors, and represent their research and opinions, not that of Duke University. Some materials and descriptions may include offensive content. More info